Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes

Aim: This trial evaluated the potential for improving glycaemic control by intensifying a conventional twice‐daily therapy with premixed human insulin (HI) to a thrice‐daily regimen using premixed formulations of biphasic insulin aspart (BIAsp) in patients with type 1 or type 2 diabetes. Methods: ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2008-03, Vol.10 (3), p.229-237
Hauptverfasser:	Clements, M. R., Tits, J., Kinsley, B. T., Råstam, J., Friberg, H. H., Ligthelm, R. J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged biphasic insulin aspart Blood Glucose - metabolism Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Drug Administration Schedule Female Humans Hypoglycemia - blood Hypoglycemia - metabolism Hypoglycemic Agents - administration & dosage Insulin - administration & dosage Insulin - analogs & derivatives Insulin Aspart Male Middle Aged Quality of Life Treatment Outcome type 1 diabetes type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!